Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease

Ann Intern Med. 2021 Sep;174(9):1345. doi: 10.7326/L21-0441.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Autoimmune Diseases* / complications
  • Autoimmune Diseases* / drug therapy
  • Humans
  • Melanoma* / drug therapy